Characteristics and Determinants of Partial Remission in Children with Type 1 Diabetes Using the Insulin-Dose-Adjusted A1C Definition

被引:34
|
作者
Pecheur, Aurore [1 ]
Barrea, Thierry [1 ]
Vandooren, Valerie [1 ]
Beauloye, Veronique [1 ]
Robert, Annie [2 ]
Lysy, Philippe A. [1 ]
机构
[1] Catholic Univ Louvain, Clin Univ St Luc, Pediat Endocrinol Unit, B-1200 Brussels, Belgium
[2] Catholic Univ Louvain, Inst Rech Expt & Clin, Pole Epidemiol & Biostat, B-1200 Brussels, Belgium
关键词
BETA-CELL MASS; YOUNG-CHILDREN; MELLITUS; ADOLESCENTS; AUTOIMMUNE; HONEYMOON; PERIOD; TRIAL; PHASE; RISK;
D O I
10.1155/2014/851378
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To evaluate the characteristics and determinants of partial remission (PR) in Belgian children with type 1 diabetes (T1D), we analyzed records of 242 children from our center. Clinical and biological features were collected at diagnosis and during follow-up. PR was defined using the insulin-dose-adjusted A1C definition. PR occurred in 56.2% of patients and lasted 9.2 months (0.5 to 56.6). 25.6% of patients entered T1D with DKA, which correlated with lower PR incidence (17.6% versus 82.3% when no DKA). In our population, lower A1C levels at diagnosis were associated with higher PR incidence and in young children (0-4 years) initial A1C levels negatively correlated with longer PR. Early A1C levels were predictive of PR duration since 34% of patients had long PRs (> 1 year) when A1C levels were <= 6% after 3 months whereas incidence of long PR decreased with higher A1Cs. C-peptide levels were higher in patients entering PR and remained higher until 3 years after diagnosis. Initial antibody titers did not influence PR except for anti-IA2 titers that correlated with A1C levels after 2 years. Presence of 2 versus 1 anti-islet antibodies correlated with shorter PR. PR duration did not influence occurrence of severe hypoglycemia or diabetes-related complications but was associated with lower A1C levels after 18 months. We show that, at diagnosis of T1D, parameters associated with beta-cell mass reserve (A1C, C-peptide, and DKA) correlate with the occurrence of PR, which affects post-PR A1C levels. Further research is needed to determine the long-term significance of PR.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Features of partial remission in children with type 1 diabetes using the insulin dose-adjusted A1c definition and risk factors associated with nonremission
    Wong, Tsz Wai Catherine
    Wong, Man Yee Shirley
    But, Wai Man Betty
    ANNALS OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2021, 26 (02) : 118 - 125
  • [2] Partial remission in children and adolescents with type 1 diabetes: an analysis based on the insulin dose-adjusted hemoglobin A1c
    Cimbek, Emine Ayca
    Bozkir, Aydin
    Usta, Deniz
    Beyhun, Nazim Ercument
    Okten, Aysenur
    Karaguzel, Gulay
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2021, 34 (10): : 1311 - 1317
  • [3] Partial Clinical Remission of Type 1 Diabetes: The Need for an Integrated Functional Definition Based on Insulin-Dose Adjusted A1c and Insulin Sensitivity Score
    Nwosu, Benjamin Udoka
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [4] Insulin-dose-adjusted HbA1c-defined partial remission phase in a paediatric populationwhen is the honeymoon over?
    Neylon, O. M.
    White, M.
    O'Connell, M. A.
    Cameron, F. J.
    DIABETIC MEDICINE, 2013, 30 (05) : 627 - 628
  • [5] Partial remission in type 1 diabetes and associated factors: Analysis based on the insulin dose-adjusted hemoglobin A1c in children and adolescents from a regional diabetes center, Auckland, New Zealand
    Chiavaroli, Valentina
    Derraik, Jose G. B.
    Jalaludin, Muhammad Y.
    Albert, Benjamin B.
    Ramkumar, Selvarajan
    Cutfield, Wayne S.
    Hofman, Paul L.
    Jefferies, Craig A.
    PEDIATRIC DIABETES, 2019, 20 (07) : 892 - 900
  • [6] Partial Remission Definition: Validation based on the insulin dose-adjusted HbA1c (IDAA1C) in 129 Danish Children with New-Onset Type 1 Diabetes
    Andersen, Marie Louise C. Max
    Hougaard, Philip
    Porksen, Sven
    Nielsen, Lotte B.
    Fredheim, Siri
    Svensson, Jannet
    Thomsen, Jane
    Vikre-Jorgensen, Jennifer
    Hertel, Thomas
    Petersen, Jacob S.
    Hansen, Lars
    Mortensen, Henrik B.
    PEDIATRIC DIABETES, 2014, 15 (07) : 469 - 476
  • [7] PARTIAL CLINICAL REMISSION IN TYPE 1 DIABETES: A COMPARISON OF INSULIN-DOSE ADJUSTED HEMOGLOBIN A1C OF &lt;9 AND THE TOTAL DAILY DOSE OF INSULIN OF &lt;0.3 UNITS/KG/DAY
    Lundberg, Rachel
    Marino, Katherine R.
    Maranda, Louise S.
    Alonso, Laura C.
    Nwosu, Benjamin U.
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 408 - 409
  • [8] Partial clinical remission in type 1 diabetes: a comparison of the accuracy of total daily dose of insulin of &lt;0.3 units/kg/day to the gold standard insulin-dose adjusted hemoglobin A1c of ≤9 for the detection of partial clinical remission
    Lundberg, Rachel L.
    Marino, Katherine R.
    Jasrotia, Aastha
    Maranda, Louise S.
    Barton, Bruce A.
    Alonso, Laura C.
    Nwosu, Benjamin Udoka
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2017, 30 (08): : 823 - 830
  • [9] Partial remission period based on insulin dose-adjusted HbA1c in 3, 661 German and Austrian children and adolescents with type 1 diabetes
    Nagl, K.
    Hermann, J. M.
    Plamper, M.
    Schroeder, C.
    Dost, A.
    Kordonouri, O.
    Holl, R. W.
    DIABETOLOGIA, 2015, 58 : S426 - S426
  • [10] New Definition for the Partial Remission Period in Children and Adolescents with Type 1 Diabetes
    Mortensen, Henrik B.
    Hougaard, Philip
    Swift, Peter
    Hansen, Lars
    Holl, Reinhard W.
    Hoey, Hilary
    Bjoerndalen, Hilde
    de Beaufort, Carine
    Chiarelli, Francesco
    Danne, Thomas
    Schoenle, Eugen J.
    Aman, Jan
    DIABETES CARE, 2009, 32 (08) : 1384 - 1390